Development of anti-angiogenic erlotinib liposomal...

  • Main
  • 2019 / 4
  • Development of anti-angiogenic erlotinib liposomal...
Drug Delivery and Translational Research 2019 / 4

Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach

Dhoble, Sagar, Patravale, Vandana
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Drug Delivery and Translational Research
DOI:
10.1007/s13346-019-00641-2
Date:
April, 2019
File:
PDF, 2.42 MB
english, 2019
Conversion to is in progress
Conversion to is failed